FTC blesses Teva's Cephalon buy, with caveats
11 October 2011
Donna Young
Please Login to read the full article.
11 October 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
- BDSI CEO: Shared fentanyl REMS puts Onsolis on level playing field
- Teva to take $13m spanner from works to close $6.8bn Cephalon deal
- Generic Provigil hits US market, but Mylan sues over an FDA 180-day exclusivity ruling
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
